Shares of Pfizer rise as Q3 earnings beat estimates
2 November 2022Shares of Pfizer rise as Q3 earnings beat estimates
Pfizer Inc. (NYSE:PFE) reported its latest financial results for the third quarter before the opening bell on Tuesday in the US.
The US pharmaceutical company reported revenue of $22.638 billion (down 6% year-over-year) vs. $21.072 billion expected.
Earnings per share reported at $1.78 per share vs. $1.387 per share estimate.
David Denton, CFO of Pfizer commented on the results: ”Third-quarter results demonstrated commercial strength across many areas of our business but was somewhat obscured by the incredibly strong performance in the prior year. We saw strong operational performance this quarter from key brands such as Paxlovid and Eliquis, particularly in the U.S., as well as the continued impressive launch of Prevnar 20 for adults in the U.S. In addition, we continue to make progress toward our goal of adding at least $25 billion in risk adjusted 2030 revenues to Pfizer’s portfolio through business development. Since we last reported earnings, we completed the acquisitions of Biohaven and Global Blood Therapeutics, each of which bring significant scientific breakthroughs to Pfizer and which present opportunities where we believe we can add great value.”
”I look forward to continuing to execute on Pfizer’s strategies to deliver breakthroughs to patients and value to shareholders,” Denton concluded.
The stock was up by around 3% on Tuesday, trading at $47.94 a share.
Stock performance
- 1 month: +7.85%
- 3 months: -3.50%
- Year-to-date: -18.80%
- 1 year: +5.50%
Pfizer price targets
- Morgan Stanley: $50
- Barclays: $44
- SVB Leerink: $48
- Wells Fargo: $55
- Citigroup: $57
- B of A Securities: $70
Pfizer is the 27th largest company in the world with a market cap of $269.29 billion.
You can trade Pfizer Inc. (NYSE:PFE) and many other stocks from the NYSE, NASDAQ, HKEX, ASX, LSE and DE with GO Markets as a Share CFD.
Sources: Pfizer Inc., TradingView, MetaTrader 5, Benzinga, CompaniesMarketCap
Disclaimer: Articles are from GO Markets analysts and contributors and are based on their independent analysis or personal experiences. Views, opinions or trading styles expressed are their own, and should not be taken as either representative of or shared by GO Markets. Advice, if any, is of a ‘general’ nature and not based on your personal objectives, financial situation or needs. Consider how appropriate the advice, if any, is to your objectives, financial situation and needs, before acting on the advice.
Next Article
Stocks down, USD and Yields up ahead of key FOMC meeting
US stocks slid in a choppy session where a positive open soon sold off sharply on the back of a positive JOLTS report sparking a “good news is bad news” reaction in equity markets. The JOLTS survey showed that job openings surged in September, rising to 10.72 million, well above the expected 9.85 million, this saw rate hike odds soaring ahea...
Previous Article
NIO October delivery numbers have arrived – the stock is up
NIO Inc. (NYSE:NIO) reported its latest delivery numbers for October on Tuesday. The Chinese electric vehicle company delivered 10,059 cars last mo...
